MedTrace Logo

Ketogenic Diet Therapy for Autism Spectrum Disorder

NCT02477904 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2019-09-20

No results posted yet for this study

Summary

This study will assess the effectiveness of the ketogenic diet (high-fat, low-carbohydrate, and moderate protein) in treating autism spectrum disorder (ASD). Three study groups will be comprised of children (2-21 years of age) based on whether or not they have ASD and receive the ketogenic diet - ASD/ketogenic diet, ASD/non-ketogenic diet, and non-ASD/non-ketogenic diet.

Conditions

Interventions

OTHER

Ketogenic Diet

Dietary

Sponsors & Collaborators

  • University of Hawaii

    collaborator OTHER

  • Shriners Hospitals for Children

    lead OTHER

Principal Investigators

  • Ryan W Lee, MD · Shriners Hospitals for Children, Honolulu

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-04-28
Completion
2017-04-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02477904 on ClinicalTrials.gov